Ares Capital (ARCC) Stock Price & Analysis

ARCC$19.17+0.06 +0.31%
Asset ManagementLarge Cap
Compare
Market cap$13.84BEnterprise value$28.46BRevenue (TTM)$2.42BMarket positionTop 25%

Score

46
Neutral
Value
50
Quality
55
Growth
33

AI Analysis

Snapshot

Ares Capital is a mixed profile at 46/100 — Value 50, Growth 33, Quality 55. Under the hood: P/E 16.0, rich vs its own history, plus revenue compounding ~28% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

50
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

33
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

55
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Ares Capital Corporation (ARCC) last printed $19.17. Equity value is $13.84B. Trailing earnings multiple 15.82. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$737M$974M$1.12B$1.11B$858M$2.05B$1.2B$2.17B$2.37B$2.24B

About

Ares Capital Corporation (ARCC) operates as a Business Development Company (BDC), delivering diverse financing solutions predominantly to middle-market enterprises. The firm's expertise lies in facilitating various corporate actions, including funding acquisitions, recapitalizations, and leveraged buyouts. It also extends mezzanine debt, assists with corporate restructurings, and provides crucial rescue financing, in addition to offering growth capital and general refinancing options. ARCC primarily targets investments in companies within the basic and growth manufacturing, business services, consumer products, healthcare (both products and services), and information technology service sectors. Opportunistically, it also explores prospects in industries such as restaurants, retail, oil and gas, and the broader technology space. Geographically, ARCC maintains a broad reach across the United States. Its New York office oversees investments in the Northeast, Mid-Atlantic, Southeast, and Southwest regions. The Chicago office manages opportunities in the Midwest, while its Los Angeles presence covers the Western region. In terms of deal parameters, ARCC typically commits between $20 million and $200 million per investment, with an upper limit of $400 million, targeting companies that generate an EBITDA of $10 million to $250 million. For debt-specific placements, the investment range is generally $10 million to $100 million. The company employs a wide array of financial instruments, including revolving credit facilities, first and second lien loans, unitranche structures, warrants, mezzanine debt, private high yield, junior capital, and subordinated debt, alongside selective non-control preferred and common equity investments. ARCC also evaluates participation in senior and subordinated debt financings led by other parties and strategically acquires stressed or discounted debt. It frequently assumes a lead or agent role in its transactions and actively seeks board representation in its portfolio companies.

Ares Capital (ARCC) Stock Price & Analysis

ARCC price $19.17 +0.06 +0.31%

Ticker
ARCC
Price
$19.17
Change
+0.06 +0.31%
Market cap
$13.84B
P/E
15.82
Forward P/E
9.97
Dividend yield
9.87%
Beta
0.64
Sector
Financial Services
Industry
Asset Management
Stocklytics score
46
Value
50
Quality
55
Growth
33

Stocklytics score rationale: value 50, quality 55, growth 33.

AI Score 75. Ares Capital Corporation (ARCC) has a solid market capitalization of approximately $13.8 billion and a price of $19.11, with a price-to-earnings ratio of about 15.7, indicating reasonable valuation. The company demonstrates strong profitability with a net profit margin of 36.2% and a consistent dividend yield of 10.05%, suggesting good returns for investors

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener